跳至主要内容
临床试验/EUCTR2012-003359-12-NL
EUCTR2012-003359-12-NL进行中(未招募)不适用

The effect of a high and low protamine-to-heparin dosing on perioperative hemostasis: a randomized clinical trial. - Ratio-PRO study

VU University Medical Center0 个研究点目标入组 98 人开始时间: 2013年8月14日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients undergoing coronary artery bypass graft (CABG) surgery.
  • Age 18-85 years
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 28
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • Re-operations
  • Emergency operation
  • Patients with a history of hematologic disorders or renal replacement therapy.
  • Patients with a body mass index (BMI) below 18 kg/m2 or above 35 kg/m2

研究者

发起方
VU University Medical Center

相似试验